(Q52464076)

2 May 2018

reason for preferred rank

title

The physiological action of gliclazide: β-cell function and insulin resistance (English)

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

27 November 2022

The physiological action of gliclazide: beta-cell function and insulin resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794266

27 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

27 November 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

27 November 2022

1

D R Matthews

1 reference

2 May 2018

Irene M. Stratton

3

object named as

I. Stratton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794266

27 November 2022

author name string

D. R. Matthews

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794266

27 November 2022

J. P. Hosker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794266

27 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1794266

27 November 2022

publication date

1 January 1991

1 reference

2 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0168822791900082?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

https://api.elsevier.com/content/article/PII:0168822791900082?httpAccept=text/plain

27 November 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

Diabetes Research and Clinical Practice

27 November 2022

published in

1 reference

2 May 2018

volume

14 Suppl 2

1 reference

2 May 2018

page(s)

S53-9

1 reference

2 May 2018

Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

The beta-cell glibenclamide receptor is an ADP-binding protein

27 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

The effect of glibenclamide administration on insulin sensitivity and insulin binding to monocytes in normal subjects.

27 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.

27 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

Glucose clamp technique: a method for quantifying insulin secretion and resistance

27 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

Unbiased and flexible iterative computer program to achieve glucose clamping

27 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

Quantitative estimation of insulin sensitivity

27 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

27 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

27 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90008-2

27 November 2022

Identifiers

1 reference

2 May 2018

1 reference

2 May 2018